Vital Therapies to Webcast Presentation at Upcoming Investor Conference

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced that the company will participate in the Stifel 2017 Healthcare Conference in New York, NY.

The Company will be presenting at 9:30 AM Eastern on Wednesday, November 15, 2017.  A live webcast of the presentation will be available on the Investor Relations page of the Company's website at: http://ir.vitaltherapies.com/. An archive of the presentation will be available for replay following the conference.

About Vital Therapies, Inc.
Vital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting the treatment of acute forms of liver failure.  The Company’s ELAD System is an extracorporeal human allogeneic cellular liver therapy currently in phase 3 clinical trials. Vital Therapies, Inc. is based in San Diego, California.  Vital Therapies® and ELAD® are trademarks of Vital Therapies, Inc.

Contact:
Vital Therapies, Inc. 
Al Kildani
Vice President, Investor Relations and Business Development
858-673-6840
akildani@vitaltherapies.com

Source: Vital Therapies, Inc.

* Page content (in order of occurrence in the default page.html.twig): * - node: Fully loaded node, if there is an automatically-loaded node * associated with the page and the node ID is the second argument in the * page's path (e.g. node/12345 and node/12345/revisions, but not * comment/reply/12345). * * Regions: * - page.header: Items for the header region. * - page.help: Dynamic help text, mostly for admin pages. * - page.content: The main content of the current page. * - page.sidebar_first: Items for the first sidebar. * - page.sidebar_last: Items for the second sidebar. * - page.footer: Items for the footer region. * * @see template_preprocess_page() * @see html.html.twig */ #}

Vital Therapies to Webcast Presentation at Upcoming Investor Conference

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced that the company will participate in the Stifel 2017 Healthcare Conference in New York, NY.

The Company will be presenting at 9:30 AM Eastern on Wednesday, November 15, 2017.  A live webcast of the presentation will be available on the Investor Relations page of the Company's website at: http://ir.vitaltherapies.com/. An archive of the presentation will be available for replay following the conference.

About Vital Therapies, Inc.
Vital Therapies, Inc. is a biotherapeutic company developing a cell-based therapy targeting the treatment of acute forms of liver failure.  The Company’s ELAD System is an extracorporeal human allogeneic cellular liver therapy currently in phase 3 clinical trials. Vital Therapies, Inc. is based in San Diego, California.  Vital Therapies® and ELAD® are trademarks of Vital Therapies, Inc.

Contact:
Vital Therapies, Inc. 
Al Kildani
Vice President, Investor Relations and Business Development
858-673-6840
akildani@vitaltherapies.com

Source: Vital Therapies, Inc.